- Systematic mapping review of guidelines for BRCA1/2 genetic testing globally: investigating geographic and regional disparities in health equity for women and families at risk for hereditary ovarian cancer.
- Hughes BN, Jorgensen KA, Cummings S, Morah D, Krause K, Rauh-Hain JA, Herzog TJ.
- Int J Gynecol Cancer. 2022 Nov 11:ijgc-2022-003913. doi: 10.1136/ijgc-2022-003913. Epub ahead of print.
- PMID: 36368709
- PubMed abstract
- Source abstract
- Review
- Prostate Cancer Has High Rate of Actionable Mutations, Underscoring Need for Testing.
- Rosa K, Antonarakis ES.
- OncLive. 2022 Nov 11.
- Review
- Free Full Text
- Use of Breast Cancer Risk Factors to Identify Risk-Adapted Starting Age of Screening in China.
- Zheng Y, Dong X, Li J, Qin C, Xu Y, Wang F, Cao W, Xia C, Yu Y, Zhao L, Wu Z, Luo Z, Chen W, Li N, He J.
- JAMA Netw Open. 2022 Nov 1;5(11):e2241441. doi: 10.1001/jamanetworkopen.2022.41441.
- PMID: 36355372
- PubMed abstract
•• Commentary:
Risk-Based Approaches to Breast Cancer Screening in China.
- PMID: 36355377
- PubMed abstract
- Free Full Text